172 related articles for article (PubMed ID: 1724691)
1. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
Chan TM; Lok AS; Cheng IK
Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in renal dialysis patients in Glasgow.
McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
6. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission.
Cendoroglo Neto M; Draibe SA; Silva AE; Ferraz ML; Granato C; Pereira CA; Sesso RC; Gaspar AM; Ajzen H
Nephrol Dial Transplant; 1995; 10(2):240-6. PubMed ID: 7538651
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
[TBL] [Abstract][Full Text] [Related]
8. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
[TBL] [Abstract][Full Text] [Related]
9. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
Medin C; Allander T; Roll M; Jacobson SH; Grillner L
Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
[TBL] [Abstract][Full Text] [Related]
10. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
Huang CC; Wu MS; Lin DY; Liaw YF
Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C in renal transplant recipients.
Chan TM; Lok AS; Cheng IK
Transplantation; 1991 Nov; 52(5):810-3. PubMed ID: 1949165
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Noh H; Kang SW; Choi SH; Shin SK; Seo BJ; Lee IH; Choi KH; Han DS; Kim HS; Lee HY
Yonsei Med J; 1998 Apr; 39(2):116-21. PubMed ID: 9587251
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
[TBL] [Abstract][Full Text] [Related]
16. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.
Cendoroglo Neto M; Manzano SI; Canziani ME; Silva AE; Cirenza LF; Sesso Rde C; Ajzen H; Draibe SA
Artif Organs; 1995 Mar; 19(3):251-5. PubMed ID: 7539998
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays.
Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F
Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three different tests for assessment of hepatitis C virus in dialysis patients.
Castelnovo C; Lunghi G; De Vecchi A; Grancini A; Como G; Graziani G; Scalamogna A; Ponticelli C
Perit Dial Int; 1995; 15(6):241-5. PubMed ID: 7578501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
